HBIO - HARVARD BIOSCIENCE INC

4.87
-0.200   -4.107%

Share volume: 39,736
Last Updated: 03-27-2026
Measuring And Control Equipment/Lab Analytical Instruments: -0.11%

PREVIOUS CLOSE
CHG
CHG%
$5.07
-0.20
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
8%
Profitability 0%
Dept financing 13%
Liquidity 20%
Performance 12%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-8.80%
1 Month
724.03%
3 Months
635.32%
6 Months
1,007.32%
1 Year
698.36%
2 Year
14.86%
Key data
Stock price
$4.87
P/E Ratio 
N/A
DAY RANGE
$4.75 - $5.04
EPS 
-$1.28
52 WEEK RANGE
$0.28 - $5.75
52 WEEK CHANGE
$760.42
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
44.720 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-06-2025
BETA 
1.69
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$50,434
AVERAGE 30 VOLUME 
$258,989
Company detail
CEO: James W. Green
Region: US
Website: harvardbioscience.com
Employees: 490
IPO year: 2001
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as instruments and accessories for tissue and organ-based lab research.

Recent news